(LEAD) Samsung Biologics Q3 net income down over 20 pct
AI Summary
Samsung Biologics reported that its net income fell by more than 20% in the third quarter. The brief report does not include the reasons for the decline or additional financial figures.
(ATTN: CHANGES headline; ADDS additional info at bottom, photo)